Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain, Journal of Neuroscience Research, vol.538, issue.3, pp.305-316, 1993. ,
DOI : 10.1002/jnr.490350310
Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes, Diabetes, vol.62, issue.9, pp.3120-3151, 2013. ,
DOI : 10.2337/db13-0214
Permeability of the mouse blood???brain barrier to murine interleukin-2: predominance of a saturable efflux system, Brain, Behavior, and Immunity, vol.18, issue.5, pp.434-476, 2004. ,
DOI : 10.1016/j.bbi.2003.09.013
Imaging the microanatomy of astrocyte???T-cell interactions in immune-mediated inflammation, Frontiers in Cellular Neuroscience, vol.7, p.58, 2013. ,
DOI : 10.3389/fncel.2013.00058
In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration, Proceedings of the National Academy of Sciences, vol.108, issue.15, pp.6282-6289, 2011. ,
DOI : 10.1073/pnas.1015239108
Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer???s disease pathology, Nature Communications, vol.299, p.7967, 2015. ,
DOI : 10.1038/nprot.2006.275
URL : http://doi.org/10.1038/ncomms8967
PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease, Nature Medicine, vol.1, issue.2, 2016. ,
DOI : 10.1038/nm.4022
IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins, Journal of Neuroimmunology, vol.160, issue.1-2, pp.146-53, 2005. ,
DOI : 10.1016/j.jneuroim.2004.11.006
Cytokine Levels and Phagocytic Activity in Patients with Alzheimer???s Disease, Gerontology, vol.48, issue.3, pp.128-160, 2002. ,
DOI : 10.1159/000052830
Modulation of inflammation in transgenic models of Alzheimer???s disease, Journal of Neuroinflammation, vol.11, issue.1, p.25, 2014. ,
DOI : 10.1186/1742-2094-9-106
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata, JAMA Dermatology, vol.150, issue.7, pp.748-51, 2014. ,
DOI : 10.1001/jamadermatol.2014.504
Massive gliosis induced by interleukin-6 suppresses A?? deposition in vivo: evidence against inflammation as a driving force for amyloid deposition, The FASEB Journal, vol.24, issue.2, pp.548-59, 2010. ,
DOI : 10.1096/fj.09-141754
Hippocampal expression of murine TNF?? results in attenuation of amyloid deposition in vivo, Molecular Neurodegeneration, vol.6, issue.1, p.16, 2011. ,
DOI : 10.1016/S0002-9440(10)65416-8
IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior, Neuron, vol.85, issue.3, pp.519-552, 2015. ,
DOI : 10.1016/j.neuron.2014.11.020
Amyloid-?? causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons, Molecular Psychiatry, vol.21, issue.2, pp.206-228, 2009. ,
DOI : 10.1016/j.cardiores.2004.05.018
Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer, Clinical Immunology, vol.151, issue.2, pp.114-140, 2014. ,
DOI : 10.1016/j.clim.2014.02.003
Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors, Journal of Reproductive Immunology, vol.77, issue.2, pp.152-60, 2008. ,
DOI : 10.1016/j.jri.2007.06.051
Regulatory T cells delay disease progression in Alzheimer-like pathology, Brain, vol.139, issue.4, 2016. ,
DOI : 10.1093/brain/awv408
URL : http://doi.org/10.1093/brain/awv408
Interleukin-2 Transcripts in Human and Rodent Brains: Possible Expression by Astrocytes, Journal of Neurochemistry, vol.64, issue.5, pp.1928-1964, 1995. ,
DOI : 10.1046/j.1471-4159.1995.64051928.x
Frontotemporal dementia and its subtypes: a genome-wide association study, The Lancet Neurology, vol.13, issue.7, pp.686-99, 2014. ,
DOI : 10.1016/S1474-4422(14)70065-1
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nature Immunology, vol.4, issue.4, pp.330-336, 2003. ,
DOI : 10.1038/ni904
Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology, Neuron, vol.85, issue.3, pp.534-582, 2015. ,
DOI : 10.1016/j.neuron.2014.12.068
URL : http://doi.org/10.1016/j.neuron.2014.12.068
Neurotoxic consequences of central long-term administration of interleukin-2 in rats, Neuroscience, vol.79, issue.3, pp.799-818, 1997. ,
DOI : 10.1016/S0306-4522(97)00040-7
Alzheimer's disease: the amyloid cascade hypothesis, Science, vol.256, issue.5054, pp.184-189, 1992. ,
DOI : 10.1126/science.1566067
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial, The Lancet Diabetes & Endocrinology, vol.1, issue.4, pp.295-305, 2013. ,
DOI : 10.1016/S2213-8587(13)70113-X
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus, Nature Medicine, vol.12, issue.9, pp.991-994, 2016. ,
DOI : 10.1038/ni1467
The Jak-Stat Pathway: Cytokine Signalling from the Receptor to the Nucleus, Journal of Receptors and Signal Transduction, vol.57, issue.1-4, pp.75-120, 1999. ,
DOI : 10.1038/386288a0
Innate immunity in Alzheimer's disease, Nature Immunology, vol.22, issue.3, pp.229-265, 2015. ,
DOI : 10.1016/j.neuron.2006.01.022
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival, EMBO Molecular Medicine, vol.32, issue.(Suppl), pp.64-79, 2013. ,
DOI : 10.1002/emmm.201201544
URL : http://doi.org/10.1002/emmm.201201544
Immune attack: the role of inflammation in Alzheimer disease, Nature Reviews Neuroscience, vol.19, issue.6, pp.358-72, 2015. ,
DOI : 10.1016/j.neurobiolaging.2011.09.040
Mutant presenilins specifically elevate the levels of the 42 residue ??-amyloid peptide in vivo: evidence for augmentation of a 42-specific ?? secretase, Human Molecular Genetics, vol.13, issue.2, pp.159-70, 2004. ,
DOI : 10.1093/hmg/ddh019
A??40 Inhibits Amyloid Deposition In Vivo, Journal of Neuroscience, vol.27, issue.3, pp.627-660, 2007. ,
DOI : 10.1523/JNEUROSCI.4849-06.2007
CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice, The FASEB Journal, vol.24, issue.8, pp.3093-102, 2010. ,
DOI : 10.1096/fj.10-155317
AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice, Gene Therapy, vol.154, issue.7, pp.724-757, 2012. ,
DOI : 10.1371/journal.pone.0006197
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases, Nature Reviews Immunology, vol.134, issue.5, pp.283-94, 2015. ,
DOI : 10.1016/S0140-6736(00)02799-9
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice, The FASEB Journal, vol.27, issue.1, pp.187-98, 2013. ,
DOI : 10.1096/fj.12-208660
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528309
Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety., Behavioral Neuroscience, vol.113, issue.5, pp.1030-1071, 1999. ,
DOI : 10.1037/0735-7044.113.5.1030
STAT3 promotes corticospinal remodelling and functional recovery after spinal cord injury, EMBO reports, vol.23, issue.10, pp.931-938, 2013. ,
DOI : 10.1016/S0140-6736(11)60547-3
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807223
Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-?? using BV2 microglial cells and APP/PS1 transgenic mice, Journal of Neuroinflammation, vol.12, issue.1, p.41, 2015. ,
DOI : 10.4049/jimmunol.181.9.6503
Enhanced Proteolysis of ??-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death, Neuron, vol.40, issue.6, pp.1087-93, 2003. ,
DOI : 10.1016/S0896-6273(03)00787-6
Revisiting the Mechanisms of CNS Immune Privilege, Trends in Immunology, vol.36, issue.10, pp.569-77, 2015. ,
DOI : 10.1016/j.it.2015.08.006
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR, Neuroscience Letters, vol.79, issue.1-2, 1987. ,
DOI : 10.1016/0304-3940(87)90696-3
??-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis, Neurobiology of Aging, vol.33, issue.12, pp.2807-2823, 2012. ,
DOI : 10.1016/j.neurobiolaging.2012.02.015
A new role for astrocytes: ??-amyloid homeostasis and degradation, Trends in Molecular Medicine, vol.9, issue.7, pp.281-283, 2003. ,
DOI : 10.1016/S1471-4914(03)00109-6
Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion, Journal of Neuroscience Research, vol.34, issue.4, pp.441-447, 1999. ,
DOI : 10.1002/(SICI)1097-4547(19990515)56:4<441::AID-JNR11>3.0.CO;2-G
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning, Journal of Neurological Disorders, vol.03, issue.01, 0196. ,
DOI : 10.4172/2329-6895.1000196
Transplanted astrocytes internalize deposited ??-amyloid peptides in a transgenic mouse model of Alzheimer's disease, Glia, vol.26, issue.2, pp.154-63, 2008. ,
DOI : 10.1002/glia.20599
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients, Journal of Autoimmunity, vol.58, pp.48-58, 2015. ,
DOI : 10.1016/j.jaut.2015.01.001
URL : https://hal.archives-ouvertes.fr/hal-01112156
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis, New England Journal of Medicine, vol.365, issue.22, pp.2067-77, 2011. ,
DOI : 10.1056/NEJMoa1105143
Regulatory T Cells and Immune Tolerance, Cell, vol.133, issue.5, pp.775-87, 2008. ,
DOI : 10.1016/j.cell.2008.05.009
Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain, Brain Research, vol.625, issue.2, pp.347-50, 1993. ,
DOI : 10.1016/0006-8993(93)91080-C
Comparative effect of IL-2 and IL-6 on morphology of cultured hippocampal neurons from fetal rat brain, Brain Research, vol.715, issue.1-2, pp.9-16, 1996. ,
DOI : 10.1016/0006-8993(95)01291-5
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders, J Alzheimers Dis, vol.13, pp.359-69, 2008. ,
Innate Immune System and Inflammation in Alzheimer's Disease: From Pathogenesis to Treatment, Neuroimmunomodulation, vol.21, issue.2-3, pp.79-87, 2014. ,
DOI : 10.1159/000356529
Chronic Interleukin-1?? Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood Brain Barrier Permeability without Overt Neurodegeneration, Journal of Neuroscience, vol.27, issue.35, pp.9301-9310, 2007. ,
DOI : 10.1523/JNEUROSCI.1418-07.2007
Astrocyte-Apolipoprotein E Associations in Senile Plaques in Alzheimer Disease and Vascular Lesions, Journal of Neuropathology and Experimental Neurology, vol.56, issue.4, pp.376-81, 1997. ,
DOI : 10.1097/00005072-199704000-00006
Interleukin-2 Enhances Dendritic Development and Spinogenesis in Cultured Hippocampal Neurons, The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, vol.17, issue.6, pp.1017-1040, 2010. ,
DOI : 10.1002/ar.21118
Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease, Neuron, vol.49, issue.4, pp.489-502, 2006. ,
DOI : 10.1016/j.neuron.2006.01.022
The Brain as a Target for Inflammatory Processes and Neuroprotective Strategies, Annals of the New York Academy of Sciences, vol.410, issue.1, pp.23-34, 2007. ,
DOI : 10.1196/annals.1403.002
Regulation of NMDA receptor trafficking by amyloid-??, Nature Neuroscience, vol.23, issue.8, pp.1051-1059, 2005. ,
DOI : 10.1126/science.285.5433.1569
Cerebral Vascular Leak in a Mouse Model of Amyloid Neuropathology, Journal of Cerebral Blood Flow & Metabolism, vol.123, issue.10, pp.1646-54, 2014. ,
DOI : 10.1126/science.1241224
Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model, Microcirculation, vol.10, pp.463-70, 2003. ,
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease???like pathology and cognitive decline, Nature Medicine, vol.21, issue.12, pp.1812-1821, 2012. ,
DOI : 10.1159/000322588
Interleukin-2 does not cross the blood-brain barrier by a saturable transport system, Brain Research Bulletin, vol.34, issue.2, pp.103-112, 1994. ,
DOI : 10.1016/0361-9230(94)90005-1
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nature Biotechnology, vol.49, issue.3, pp.321-329, 2005. ,
DOI : 10.1128/JVI.76.2.791-801.2002
The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice, Neurobiology of Aging, vol.22, issue.1, pp.49-61, 2001. ,
DOI : 10.1016/S0197-4580(00)00181-0
Regulatory T cells exert checks and balances on self tolerance and autoimmunity, Nature Immunology, vol.104, issue.1, pp.7-13, 2010. ,
DOI : 10.1038/ni.1818
Adult mouse astrocytes degrade amyloid-?? in vitro and in situ, Nature Medicine, vol.9, issue.4, pp.453-460, 2003. ,
DOI : 10.1038/nm838
Cerebral regulatory T??cells restrain microglia/macrophage-mediated inflammatory responses via IL-10, European Journal of Immunology, vol.7, issue.Pt 6, pp.180-91, 2015. ,
DOI : 10.1002/eji.201444823
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293323
Amyloid ??-protein (A??)1-40 protects neurons from damage induced by A??1-42 in culture and in rat brain, Journal of Neurochemistry, vol.22, issue.3, pp.609-628, 2003. ,
DOI : 10.1046/j.1471-4159.2003.02018.x